BRADLEY FOSTER & SARGENT INC/CT

Position in RGNX — REGENXBIO Inc.

CIK 1015086 HARTFORD, CT

Position in RGNX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$223,737

-$501,288 QoQ

Shares Held

26,699

-47.0% QoQ

Ownership

0.040%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2025

4 quarters on record

Voting authority Sole 4% Shared 0% None 96%

Healthcare · as of Jun 30, 2026

BRADLEY FOSTER & SARGENT INC/CT holds $1,337,687 across 4 Biotechnology names.

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	1,286	$638,794
2	ALNY	Alnylam Pharmaceuticals, Inc.	1,351	$406,691
3	REGN	Regeneron Pharmaceuticals, Inc.	447	$278,722
4	CGTX	Cognition Therapeutics Inc	11,722	$13,480

4 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$223,737	26,699	-47.0%	Shares	Sole	2026-05-15
2025-12-31	$725,025	50,349	+0.3%	Shares	Sole	2026-02-12
2025-09-30	$484,449	50,202	-8.5%	Shares	Sole	2025-11-10
2025-06-30	$450,622	54,887	—	Shares	Sole	2025-08-11
No filing history on record for this holder in this stock.